Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Voyager Names Steven Hyman To Board

This article was originally published in Scrip

Executive Summary

Voyager Therapeutics, Inc., a gene therapy company focusing on the CNS, has appointed Steven Hyman to its board of directors. With over 20 years of scientific leadership experience, Hyman has been president of the Society for Neuroscience and since 2012; he has been director of the Stanley Centre for Psychiatric Research at the Broad Institute of Harvard and MIT. Previously Hyman was the director of the US National Institute of Mental Health and was also the founding president of the International Neuroethics Society.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts